An open label, single arm, observational, pilot study to evaluate the safety, tolerability and efficacy of Fluconazole 150 mg in subjects suffering from Tinea cruris & Tinea corporis

Dr DG Saple0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Subjects aged between 18-65 years.
•2. Subjects willing to follow the procedures as per the study protocol and voluntarily sign an
•informed consent form.
•3. Subjects with epidermal dermatophytosis confirmed by presence of fungal hyphae in KOH
•(potassium hydroxide).
•Dermatophytosis classified clinically into one of following types:
•ï?· Tinea corporis (body)
•ï?· Tinea cruris (groin)
•4. Preparation of skin scrapings from over the lesion at baseline visit
•Subjects meting all the inclusion criteria will be enrolled in the trial.

•1. Subjects with underlying immunosuppression
•2. Pregnant or lactating women
•3. Secondarily infected or eczematized lesions
•4. Subjects who received any type of anti-fungal therapy within 14 days prior to baseline visit
•5. Subjects who applied any other topical agent over the lesions prior to baseline visit
•6. Subjects incapable of understanding the protocol
•7. Patients with urine creatinine clearance < 30
•8. Any other disease, as judged by investigator (Uncontrolled diabetes, uncontrolled
•hypertension etc.) might not be suitable for subjects to be enrolled in the study

发起方

Dr DG Saple